Aekyungchemical Co., Ltd.
KRX:161000.KS
10980 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,793,723.432 | 2,176,436.883 | 1,570,089.788 | 908,851.885 | 1,017,022.178 | 1,031,357.749 | 959,818.485 | 867,743.146 | 912,104.906 | 1,161,070.476 | 1,176,144.492 | 413,887.982 |
| Cost of Revenue
| 1,617,670.318 | 1,954,291.031 | 1,412,201.025 | 802,639.094 | 921,269.326 | 932,562.489 | 828,737.254 | 740,446.235 | 833,491.655 | 1,068,457.45 | 1,092,886.11 | 388,756.02 |
| Gross Profit
| 176,053.114 | 222,145.852 | 157,888.764 | 106,212.791 | 95,752.851 | 98,795.26 | 131,081.231 | 127,296.911 | 78,613.251 | 92,613.026 | 83,258.382 | 25,131.961 |
| Gross Profit Ratio
| 0.098 | 0.102 | 0.101 | 0.117 | 0.094 | 0.096 | 0.137 | 0.147 | 0.086 | 0.08 | 0.071 | 0.061 |
| Reseach & Development Expenses
| 21,073.806 | 19,323.201 | 7,864.986 | 7,045.132 | 6,727.315 | 6,916.345 | 5,239.777 | 4,793.95 | 4,691.418 | 5,359.821 | 4,897.259 | 1,264.35 |
| General & Administrative Expenses
| 11,068.08 | 10,445.947 | 3,774.661 | 2,932.361 | 3,798.47 | 3,765.975 | 3,904.819 | 2,836.027 | 2,859.601 | 3,281.888 | 3,716.629 | 1,437.769 |
| Selling & Marketing Expenses
| 42,759.366 | 45,372.478 | 28,415.345 | 21,741.499 | 22,948.232 | 23,392.896 | 34,147.693 | 33,127.548 | 28,089.889 | 29,364.542 | 31,647.921 | 8,940.484 |
| SG&A
| 53,827.446 | 55,818.425 | 32,190.006 | 24,673.86 | 26,746.702 | 27,158.871 | 38,052.512 | 35,963.575 | 30,949.49 | 32,646.43 | 35,364.55 | 10,378.253 |
| Other Expenses
| -1,748,687.518 | 51,917.162 | 24,573.297 | 17,006.503 | 15,426.277 | 775.336 | -2,022.836 | -2,321.116 | 266.052 | 546.134 | -199.223 | 52.171 |
| Operating Expenses
| 1,748,687.518 | 127,058.788 | 64,628.289 | 48,725.495 | 48,900.294 | 46,773.628 | 55,950.272 | 52,286.638 | 46,316.784 | 51,445.884 | 51,929.381 | 16,205.197 |
| Operating Income
| 45,035.914 | 95,087.064 | 93,260.475 | 57,487.296 | 46,852.557 | 52,021.633 | 75,130.959 | 75,010.272 | 32,296.467 | 41,167.142 | 31,329.002 | 8,926.765 |
| Operating Income Ratio
| 0.025 | 0.044 | 0.059 | 0.063 | 0.046 | 0.05 | 0.078 | 0.086 | 0.035 | 0.035 | 0.027 | 0.022 |
| Total Other Income Expenses Net
| -3,330.524 | -2,314.876 | 4,377.318 | -42.215 | 76.517 | 12,778.543 | 12,262.642 | -4,692.35 | 2,157.919 | -4,891.523 | 4,371.716 | -139.357 |
| Income Before Tax
| 41,705.39 | 92,772.188 | 97,637.793 | 57,445.081 | 46,929.075 | 64,800.175 | 87,393.602 | 70,317.923 | 34,454.386 | 36,275.619 | 35,700.717 | 8,787.408 |
| Income Before Tax Ratio
| 0.023 | 0.043 | 0.062 | 0.063 | 0.046 | 0.063 | 0.091 | 0.081 | 0.038 | 0.031 | 0.03 | 0.021 |
| Income Tax Expense
| 8,262.092 | 33,408.094 | 20,348.301 | 13,119.039 | 16,555.904 | 12,072.658 | 22,662.333 | 16,950.399 | 6,502.771 | 10,070.64 | 9,082.144 | 2,029.842 |
| Net Income
| 33,097.857 | 60,147.789 | 77,372.147 | 44,405.646 | 30,505.934 | 53,088.659 | 65,098.773 | 53,750.259 | 28,332.191 | 26,580.253 | 27,157.732 | 7,239.486 |
| Net Income Ratio
| 0.018 | 0.028 | 0.049 | 0.049 | 0.03 | 0.051 | 0.068 | 0.062 | 0.031 | 0.023 | 0.023 | 0.017 |
| EPS
| 686.27 | 1,248.6 | 2,301.94 | 1,406.84 | 966.47 | 1,682 | 2,054 | 1,678 | 88.5 | 830 | 848 | 226 |
| EPS Diluted
| 685.58 | 1,248.17 | 2,300.06 | 1,406.61 | 966.47 | 1,682 | 2,054 | 1,678 | 88.5 | 830 | 848 | 226 |
| EBITDA
| 92,941.27 | 137,592.972 | 120,580.085 | 70,180.192 | 61,866.502 | 76,457.486 | 82,157.883 | 79,936.864 | 44,769.387 | 49,449.256 | 46,560.015 | 13,216.602 |
| EBITDA Ratio
| 0.052 | 0.063 | 0.077 | 0.077 | 0.061 | 0.074 | 0.086 | 0.092 | 0.049 | 0.043 | 0.04 | 0.032 |